Tepezza (teprotumumab-trbw) / Genmab, Horizon Therapeutics, Amgen, Roche 
Welcome,         Profile    Billing    Logout  

7 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Tepezza (teprotumumab-trbw) / Roche, Amgen
NCT04583735: A Study Evaluating TEPEZZA® Treatment in Patients With Chronic (Inactive) Thyroid Eye Disease

Completed
4
62
US
TEPEZZA, teprotumumab-trbw, HZN-001, Placebo, sodium chloride
Amgen
Thyroid Eye Disease, Chronic (Inactive) Thyroid Eye Disease
03/23
10/23
NCT05002998: TEPEZZA® (Teprotumumab-trbw) Post-Marketing Requirement Study

Active, not recruiting
4
313
Europe, US
Teprotumumab, TEPEZZA, Placebo, Saline Solution
Amgen
Thyroid Eye Disease
10/25
10/25
2020-005999-36: Treatment of Thyroid Eye Disease with Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study to observe safety and tolerability

Not yet recruiting
3
300
Europe
TEPROTUMUMAB, [-], Powder for concentrate for solution for infusion, TEPEZZA
Horizon Therapeutics U.S.A., Inc., HORIZON THERAPEUTICS USA, INC., Horizon Therapeutics U.S.A. Inc.,
Thyroid Eye Disease (TED), Graves' ophthalmopathy, Diseases [C] - Eye Diseases [C11]
 
 
HZNP-TEP-305, NCT06248619: A Trial to Investigate Teprotumumab Subcutaneous Administration Compared With Placebo in Male and Female Adult Participants With Moderate-to-severe Active Thyroid Eye Disease

Recruiting
3
80
Japan, US
Teprotumumab, Placebo
Amgen
Thyroid Eye Disease
08/25
03/26
NCT06563856: A Study of TEPEZZA Subcutaneous Administration in Healthy Adults

Completed
1
37
US
TEPEZZA, HZN-001, EDP
Amgen
Bioavailability, Bioequivalence
05/21
05/21
NCT06389578: A Study of TEPEZZA® Treatment in Participants With Thyroid Eye Disease

Completed
1
16
US
Teprotumumab, Tepezza
Amgen
Thyroid Eye Disease
02/23
09/23
NCT06275373: The Effect of Teprotumumab on Thyroid Eye Disease and Thyroid Dysfunction

Recruiting
N/A
100
US
Teprotumumab Injection [Tepezza], Tepezza TM
Walter Reed National Military Medical Center
Thyroid Eye Disease, Graves Ophthalmopathy, Graves Disease
05/26
12/27

Download Options